Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor

Nature Medicine

Volumn 8, Issue 11, 2002, Pages 1296-1302

  Perretti, Mauro ^a   Chiang, Nan ^b   La, Mylinh ^a   Fierro, Iolanda M ^b   Marullo, Stefano ^c   Getting, Stephen J ^a   Solito, Egle ^d   Serhan, Charles N ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c INSTITUT COCHIN   (France)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANNEXIN; ANNEXIN 1; CHEMOKINE; DEXAMETHASONE; GLUCOCORTICOID; LIPOXIN A; LIPOXIN A RECEPTOR; PROSTAGLANDIN; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; LIGAND BINDING; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASPIRIN; CELL LINE; CELLS, CULTURED; DEXAMETHASONE; HUMANS; LIPID METABOLISM; MICE; MOLECULAR SEQUENCE DATA; NEUTROPHIL ACTIVATION; PEPTIDES; RECEPTORS, CELL SURFACE; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN;

ANIMALIA;

EID: 0036852720     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm786     Document Type: Article

References (38)

1. Cotran, R.S. Inflammation: Historical perspectives, in Inflammation: Basic Principles and Clinical Correlates 3rd Edn. (eds. Gallin, J.I., Snyderman, R., Fearon, D.T., Haynes, B.F. & Nathan, C.) 5-10 (Lippincott Williams & Wilkins, Philadelphia, 1999).
2. Weissmann, G. Aspirin. Sci. Am. 264, 84-90 (1991).
3. Patrono, C. Aspirin: New cardiovascular uses for an old drug. Am. J. Med. 110, 62S-65S (2001).
4. Barnes, C.J., Hardman, W.E., Cameron, I.L. & Lee, M. Aspirin, but not sodium salicylate, indomethacin, or nabumetone, reversibly suppresses 1,2-dimethylhydrazine-induced colonic aberrant crypt foci in rats. Dig. Dis. Sci. 42, 920-926 (1997).
5. Marcus, A.J. Aspirin as prophylaxis against colorectal cancer. N. Engl. J. Med. 333, 656-658 (1995).
6. Samuelsson, B. From studies of biochemical mechanisms to novel biological mediators: Prostaglandin endoperoxides, thromboxanes and leukotrienes. in Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures 153-174 (Almqvist & Wiksell, Stockholm, 1982).
7. Vane, J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature (London) New Biol. 231, 232-235 (1971).
8. Hench, P.S., Kendall, E.C., Slocumb, C.H. & Polley, H.E. Proc. Staff Meet. Mayo Clin. 24, 181 (1949).
9. Boumpas, D.T. & Wilder, R.L. Corticosteroids, in Arthritis and Allied Conditions: A Textbook of Rheumatology 14th Edn. edn (ed. Koopman, W.I.) 827-847 (Lippincott Williams & Wilkins, Philadelphia, 2001).
10. Derry, S. & Loke, Y.K. Risk of gastrointestinal haemorrhage with long term use of aspirin: Meta-analysis. Br. Med. J. 321, 1183-1187 (2000).
11. Cronstein, B.N. & Weissmann, G. Targets for antiinflammatory drugs. Annu. Rev. Pharmacol. Toxicol. 35, 449-462 (1995).
12. Sin, Y.M., Sedgwick, A.D., Chea, E.P. & Willoughby, D.A. Mast cells in newly formed lining tissue during acute inflammation: A six day air pouch model in the mouse. Ann. Rheum. Dis. 45, 873-877 (1986).
13. Jick, H., Pinals, R.S., Ullian, R., Slone, D. & Muench, H. Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. Lancet 2, 1203-1205 (1965).
14. Flower, R.J. & Rothwell, N.J. Lipocortin-1: Cellular mechanisms and clinical relevance. Trends Pharmacol. Sci. 15, 71-76 (1994).
15. Lim, L.H., Solito, E., Russo-Marie, F., Flower, R.J. & Perretti, M. Promoting detachment of neutrophils adherent to murine postcapillary venules to control inflammation: Effect of lipocortin 1. Proc. Natl. Acad. Sci USA 95, 14535-14539 (1998).
16. 2-generation by dexamethasone is mimicked by lipocortin 1 in alveolar macrophages. J. Clin. Invest. 83, 1936-1940 (1989).
17. Serhan, C.N., Takano, T., Chiang, N., Gronert, K. & Clish, C.B. Formation of endogenous "antiinflammatory" lipid mediators by transcellular biosynthesis: Lipoxins and aspirin-triggered lipoxins inhibit neutrophil recruitment and vascular permeability. Am. J. Respir. Crit. Care Med. 161, S95-S101 (2000).
18. 4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. J. Exp. Med. 191, 1197-1207 (2000).
19. 4 that mediates chemotaxis. Nature 387, 620-624 (1997).
20. Gabay, C. & Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-454 (1999).
21. Su, S.B. et al. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 189, 395-402 (1999).
22. Linke, R.P., Bock, V., Valet, G. & Rothe, G. Inhibition of the oxidative burst response of N-formyl peptide-stimulated neutrophils by serum amyloid-A protein. Biochem. Biophys. Res. Commun. 176, 1100-1105 (1991).
23. Oliani, S.M., Paul-Clark, M.J., Christian, H.C., Flower, R.J. & Perretti, M. Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am. J. Pathol. 158, 603-615 (2001).
24. Perretti, M. et al. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nature Med. 2, 1259-1262 (1996).
25. Walther, A., Riehemann, K. & Gerke, V. A novel ligand of the formyl peptide receptor: Annexin I regulates neutrophil extravasation by interacting with the FPR. Mol. Cell. 5, 831-840 (2000).
26. Perretti, M., Getting, S.J., Solito, E., Murphy, P.M. & Gao, J.L. Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics. Am. J. Pathol. 158, 1969-1973 (2001).
27. 4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J. Immunol. 156, 2264-2272 (1996).
28. 4 receptor intracellular domains result in sustained signaling. Biochemistry 39, 13551-13557 (2000).
29. 4 ELISA. J. Pharmacol. Exp. Ther. 287, 779-790 (1998).
30. Clish, C.B. et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc. Natl. Acad. Sci. USA 96, 8247-8252 (1999).
31. Fadok, V.A. et al. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 405, 28-29 (2000).
32. Godson, C. et al. Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164, 1663-1667 (2000).
33. Liu, Y. et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162, 3639-3646 (1999).
34. Tsao, F.H.C., Meyer, K.C., Chen, X., Rosenthal, N.S. & Hu, J. Degradation of annexin I in bronchoalveolar lavage fluid from patients with cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 18, 120-128 (1998).
35. Ariel, A. et al. IL-2 induces T cell adherence to extracellular matrix: Inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase. J. Immunol. 161, 2465-2472 (1998).
36. 4: Metabolism and signal transduction. Arch. Biochem. Biophys. 385, 231-241 (2001).
37. Perretti, M. et al. Acute inflammatory response in the mouse: Exacerbation by immunoneutralization of lipocortin 1. Br. J. Pharmacol. 117, 1145-1154 (1996).
38. Cotter, M.J., Norman, K.E., Hellewell, P.G. & Ridger, V.C. A novel method for isolation of neutrophils from murine blood using negative immunomagnetic separation. Am. J. Pathol. 159, 473-481 (2001).